Antioxidant therapies may hold promise for the nearly 25 million Americans suffering from asthma, and additional 140,000 people diagnosed with pulmonary fibrosis, but to date, determining exactly how to modify them into a feasible treatment has proved challenging.

University of Vermont President Tom Sullivan and Larner College of Medicine Dean Frederick Morin, M.D., invested Philip Ades, M.D., professor of medicine and director of cardiac rehabilitation and preventive medicine, as the inaugural Philip Ades, M.D. Professor of Cardiovascular Disease Prevention December 16, 2016. The ceremony, hosted by the UVM Foundation, took place in the Hoehl Gallery in the Health Science Research Facility.

UVM Vaccine Testing Center researcher E. Ross Colgate, M.P.H., spent two years working in Bangladesh trying to understand why a rotavirus vaccine that prevents the majority of cases in the U.S. works only 40 to 60 percent of the time in Bangladeshi infants. Finding an answer could save hundreds of thousands of lives given rotavirus’ status as the leading cause of diarrhea in young children worldwide, among whom diarrhea is the second leading cause of death.

The National Institutes of Health (NIH) Common Fund has announced the first awards for its Molecular Transducers of Physical Activity in Humans Program, which will allow researchers to develop a comprehensive map of the molecular changes that occur in response to physical activity and uncover findings that could lead to people engaging in more targeted and optimized types of activity.

Medical students from The Robert Larner, M.D. College of Medicine at The University of Vermont and UVM Medical Center residents are hosting a screening of the film “Resilience: The Biology of Stress & the Science of Hope” on Wednesday, December 14, 2017 at 6:30 p.m. in Davis Auditorium.